| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |